NIKKEI 225
39,064.12 +447.02 (+1.16%) HANG SENG
18,855.78 -339.82 (-1.77%) CRUDE OIL
76.95 -0.62 (-0.80%) GOLD FUTURES
2,367.20 -25.70 (-1.07%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,553.65 -377.30 (-0.69%)
Sanofi (SNY)
After hours:
| Previous close | 48.95 |
| Open | 48.71 |
| Bid | 50.33 x 200 |
| Ask | 50.39 x 300 |
| Day's range | 48.65 - 50.58 |
| 52-week range | 42.63 - 55.72 |
| Volume | |
| Avg. volume | 1,970,241 |
| Market cap | 125.869B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 25.69 |
| EPS (TTM) | 1.96 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 2.04 (4.05%) |
| Ex-dividend date | 09 May 2024 |
| 1y target est | 59.90 |
BenzingaFirst Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg daily and 1200 mg daily, were studied. The data showed that treatment with oral rilzabrutinib at both high and low doses led to a numerical reduction in loss of asthma control (LOAC) events (the primary endpoint) and improvements in symptoms in adult patients with uncontrolled moderate-to-severe asthma. T
BenzingaHawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
A judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA (NASDAQ:SNY) to pay the state over $916 million for failing to warn non-white patients about health risks associated with their blood thinner Plavix. This decision marks an increase from an earlier $834 million judgment. Judge James Ashford of Hawaii’s First Circuit Court’s ruling follows a non-jury trial held last fall and represents the second trial in this case. The state’s Supreme Court had previously
ReutersBristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
A judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million to the state for failing to warn non-white patients of health risks from its blood thinner Plavix, up from an earlier judgment of $834 million. The ruling from Judge James Ashford, of Hawaii's First Circuit Court, follows a non-jury trial held last fall. It was the second trial in the case, after the state's Supreme Court found that the judge in the first trial that resulted in the $834 million award had made a legal error.
